Your browser doesn't support javascript.
loading
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer.
Ricciuti, B; Alessi, J V; Elkrief, A; Wang, X; Cortellini, A; Li, Y Y; Vaz, V R; Gupta, H; Pecci, F; Barrichello, A; Lamberti, G; Nguyen, T; Lindsay, J; Sharma, B; Felt, K; Rodig, S J; Nishino, M; Sholl, L M; Barbie, D A; Negrao, M V; Zhang, J; Cherniack, A D; Heymach, J V; Meyerson, M; Ambrogio, C; Jänne, P A; Arbour, K C; Pinato, D J; Skoulidis, F; Schoenfeld, A J; Awad, M M; Luo, J.
Affiliation
  • Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Elkrief A; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Wang X; Harvard School of Public Health, Boston, USA.
  • Cortellini A; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Li YY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, USA.
  • Vaz VR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Gupta H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Barrichello A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Nguyen T; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Lindsay J; Knowledge Systems Group, Dana-Farber Cancer Institute, Boston, USA.
  • Sharma B; ImmunoProfile, Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, USA.
  • Felt K; ImmunoProfile, Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, USA.
  • Rodig SJ; ImmunoProfile, Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, USA; Department of Pathology, Brigham and Women's Hospital, Boston, USA.
  • Nishino M; Department of Radiology, Brigham and Women's Hospital and Department of Imaging, Dana-Farber Cancer Institute, Boston, USA.
  • Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, USA.
  • Barbie DA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Negrao MV; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Zhang J; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Ambrogio C; Molecular Biotechnology and Health Science, University of Turin, Turin, Italy.
  • Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Arbour KC; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Pinato DJ; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Skoulidis F; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Schoenfeld AJ; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Luo J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA. Electronic address: jia_luo@dfci.harvard.edu.
Ann Oncol ; 33(10): 1029-1040, 2022 10.
Article in En | MEDLINE | ID: mdl-35872166
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication: